Elgethun Capital Management Has $3.58 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Elgethun Capital Management grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the fourth quarter, HoldingsChannel.com reports. The firm owned 7,080 shares of the healthcare conglomerate’s stock after acquiring an additional 60 shares during the quarter. Elgethun Capital Management’s holdings in UnitedHealth Group were worth $3,582,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Howard Capital Management Group LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at approximately $341,000. Principal Financial Group Inc. increased its stake in shares of UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after buying an additional 180,479 shares during the period. Jacobs Levy Equity Management Inc. bought a new stake in UnitedHealth Group during the 3rd quarter worth approximately $319,000. Tenere Capital LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at $7,030,000. Finally, Dunhill Financial LLC raised its position in UnitedHealth Group by 18.4% during the 3rd quarter. Dunhill Financial LLC now owns 418 shares of the healthcare conglomerate’s stock worth $244,000 after purchasing an additional 65 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent analyst reports. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $629.32.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $524.94 on Monday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock’s fifty day moving average price is $509.24 and its two-hundred day moving average price is $541.85. The firm has a market cap of $480.17 billion, a PE ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.83 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.